BRIEF published on 02/02/2026 at 17:15, 2 months 21 days ago Piramal Pharma Solutions dévoile une technologie de comprimés en capsule. Administration De Médicaments Centré Sur Le Patient Piramal Pharma Comprimé En Capsule Dosage Personnalisé
PRESS RELEASE published on 02/02/2026 at 17:10, 2 months 21 days ago Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities Piramal Pharma Solutions successfully develops tablet-in-capsule drug delivery system, offering flexible dosing options for oral therapies. Enhancing patient-centric solutions Drug Delivery System Patient-centric Piramal Pharma Solutions Tablet-in-Capsule Flexible Dosing Options
BRIEF published on 12/15/2025 at 07:10, 4 months 9 days ago Piramal Pharma Solutions obtient un score de recommandation client élevé Excellence Opérationnelle Fidélité Client Piramal Pharma Score Net De Promoteur Positionnement Concurrentiel
BRIEF published on 12/15/2025 at 07:10, 4 months 9 days ago Piramal Pharma Solutions Achieves High Net Promoter Score Operational Excellence Net Promoter Score Customer Loyalty Piramal Pharma Competitive Positioning
PRESS RELEASE published on 12/15/2025 at 07:05, 4 months 9 days ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
BRIEF published on 11/26/2025 at 20:30, 4 months 27 days ago Piramal Pharma Solutions garantit la conformité aux réglementations sur les nitrosamines Normes Réglementaires Sécurité Pharmaceutique Conformité Aux Nitrosamines Capacités De Test Solutions Pharmaceutiques Piramal
BRIEF published on 11/26/2025 at 20:30, 4 months 27 days ago Piramal Pharma Solutions Ensures Compliance with Nitrosamine Regulations Regulatory Standards Piramal Pharma Solutions Nitrosamine Compliance Pharmaceutical Safety Testing Capabilities
PRESS RELEASE published on 11/26/2025 at 20:25, 4 months 27 days ago Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities Piramal Pharma Solutions achieves regulatory compliance for nitrosamine impurities, ensuring safety & adherence to global guidelines, enhancing capabilities & operational excellence Regulatory Compliance Operational Excellence Patient Safety Piramal Pharma Solutions Nitrosamine Impurities
BRIEF published on 11/19/2025 at 09:00, 5 months 5 days ago L'usine de Piramal Pharma à Grangemouth obtient les certifications BPF mises à jour de la MHRA. Développement ADC Piramal Pharma Certification BPF Installations De Grangemouth Approbation De La MHRA
BRIEF published on 11/19/2025 at 09:00, 5 months 5 days ago Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications ADC Development GMP Certification MHRA Approval Piramal Pharma Grangemouth Facility
Published on 04/24/2026 at 08:00, 4 hours 10 minutes ago Caledonia Mining Corporation Plc: Annual Report on Form 20-F has been filed
Published on 04/24/2026 at 00:25, 11 hours 45 minutes ago Golden Lake Announces Closing Date of April 30, 2026 for Arrangement with McEwen Inc.
Published on 04/24/2026 at 00:15, 11 hours 55 minutes ago Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Published on 04/24/2026 at 12:00, 10 minutes ago Ringmetall SE increases revenues in the 2025 financial year thanks to successful acquisitions
Published on 04/24/2026 at 11:30, 40 minutes ago Sartorius AG Supervisory Board extends appointment of board member Florian Funck
Published on 04/24/2026 at 11:25, 44 minutes ago EQS-Adhoc: Jungheinrich AG: Preliminary figures for the first quarter of 2026: earnings significantly below prior year
Published on 04/24/2026 at 11:05, 1 hour 4 minutes ago Guerbet announces an important milestone achievement in the "Vascular Embolization" indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
Published on 04/24/2026 at 09:15, 2 hours 55 minutes ago ALPOU - Groupe POULAILLON - Dépôt du projet de note d'information
Published on 04/23/2026 at 19:27, 16 hours 43 minutes ago NRJ Group - AGM 19 mai 2026 - Mise à disposition des documents préparatoires
Published on 04/23/2026 at 19:27, 16 hours 43 minutes ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 17 hours 51 minutes ago Aéroports de Paris SA - Cession par le Groupe ADP à GMR Group de titres représentant 3,4% du capital de GAL, avec une option de cession portant sur 3,9% supplémentaires
Published on 04/23/2026 at 18:18, 17 hours 51 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
